Publication & Citation Trends
Most Cited Works
Publications
11 total
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Cited by 994
OpenAlex
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer PDF
Cited by 127
OpenAlex
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Cited by 855
OpenAlex
Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study PDF
Cited by 27
OpenAlex
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Cited by 2,327
OpenAlex
Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy?
Cited by 168
OpenAlex
Research Topics
HER2/EGFR in Cancer Research
(6)
Breast Cancer Treatment Studies
(5)
Colorectal Cancer Screening and Detection
(3)
Colorectal Cancer Surgical Treatments
(2)
Monoclonal and Polyclonal Antibodies Research
(2)
Frequent Co-Authors
Affiliations
Koo Foundation Sun Yat-Sen Cancer Center